Inhibrx Biosciences, Inc. (INBX) 8-K Current Report — March 19, 2026
Filed: March 19, 2026
Health Care
Biological Products, (No Diagnostic Substances)Inhibrx Biosciences, Inc. (INBX) 8-K current report filed with SEC EDGAR on March 19, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
Inhibrx Biosciences, Inc. 8-K Mar 19, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Earnings release covers full year ended December 31, 2025
- • Financial details not included here; refer to Exhibit 99.1 for key metrics
Other Inhibrx Biosciences, Inc. 8-K Filings
Get deeper insights on Inhibrx Biosciences, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.